Who will Trump announce as next FDA commissioner?
0.1% (24h)PolitiqueHealth & MedicineOne-OffUS PoliticsÉlection5mo
PolymarketVérifier la disponibilitéSans KYC2% de fraisDonnées de résolution vérifiéesAssez bien calibréProbabilité implicite actuelleNo announcement by December 31 17%-6.7%En tête parmi 33 options
Qualite du marche
56 / 100
Qualité moyenneVolume 24h
109 €
Liquidité
51 k €
Liquidité élevéeAchat / Vente
3.4% / 4.3%
Spread
26.5%
Spread largeVariation 7j
+0.3%
Données du marché
Mis à jour il y a 21 minutes
13 mai 26, 0:0231 déc. 26, 0:00
Tendances
Fonds fictifs uniquement, aucun argent réelCeci n'est pas un conseil financier
Résultat choisi
No announcement by December 3117%
Comparer les plateformes· Kyle Diamantas
Classé par qualité du marché, puis liquidité et volume sur 24 h| Plateforme | Qualité | Probabilité | vs référence | Vol 24h | Liq | Fraîcheur | |
|---|---|---|---|---|---|---|---|
| PolymarketCette pageMeilleur global | Moyenne | 14% | 0pt | 109 € | 51 k € | il y a 21 minutes | |
 Kalshi88% de correspondance · vérifié | Faible | 8% | -6pt | 0 € | 7,3 k € | il y a 21 minutes | Ouvrir → |
Également disponible sur Kalshi
Who will Trump nominate as FDA commissioner?
2a
54%
25%
8%
+8 résultats de plus
40 • Faible qualitéSpread largeLiquidité moyenneAmbiguïté élevée
Volume total14,6 k €
Volume 24h0 €
KALSHIRègles
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner.
- An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs.
- Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner.
- Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify.
- Media reports, speculation, or other unofficial information will not qualify.
- A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market.
Les probabilités peuvent varier en raison de structures de marché, frais et bassins de participants différents.
Tendance du volume
$1243 juil.23j de données26 juil.
Marchés Associés
When, where or how will Trump die?
36 €2025: 0%
MANIFOLD MARKETS
MANIFOLD MARKETS
California Clinic Funding Proposition
0 €Oui: 41%POLYMARKET
POLYMARKETWho will replace Graham Platner if he drops out?
252 €Troy Jackson: 99%MANIFOLD MARKETS
MANIFOLD MARKETSCalifornia Immunology Research Bond Proposition
0 €Oui: 56%POLYMARKET
POLYMARKETWill the NIH indirect cost cap stick?
879,1 €Oui: 11.4%MANIFOLD MARKETS
MANIFOLD MARKETS
Will the ACA premium tax credits be extended?
4,4 €Oui: 8%KALSHI
KALSHIActifs dans ces sujets
Actualités Associées
Polymarket odds swing: Eizenkot hits 51% as Israel campaign kicks offBlockchain.News
Polymarket: Vance leads 2028 at 19.85% as pricing trend softensBlockchain.News
White House pushes Senate Democrats to take 'historic' crypto Clarity Act ethics dealCoindesk
Senate nears bipartisan CLARITY Act deal after ethics breakthroughCrypto News
White House agrees to ethics provisions in market structure billCointelegraph
Polymarket odds show Vance at 19.85% as Epstein files critique hits tapeBlockchain.NewsRègles
This market will resolve according to the first individual Donald Trump announces as his pick to be United States Food and Drug Administration (FDA) Commissioner.
- An announcement from Donald Trump or the Trump administration stating their intent to nominate a specific individual to be United States Food and Drug Administration (FDA) Commissioner will suffice to resolve this market, regardless of whether a formal nomination actually occurs.
- Qualifying announcements must explicitly present the relevant individual as the nominee or future nominee for FDA Commissioner.
- Announcements of acting or interim appointments, or announcements which merely reveal potential candidates, will not qualify.
- Media reports, speculation, or other unofficial information will not qualify.
- A formal presidential nomination of an individual to be United States Food and Drug Administration (FDA) Commissioner will also suffice to resolve this market.